Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
01/2013
01/01/2013US8343464 Composition and method for treating eustachian tube dysfunction
01/01/2013US8343140 Devices, formulations, and methods for delivery of multiple beneficial agents
01/01/2013US8343102 Fluid driven medical injectors
01/01/2013US8343101 Fluid driven medical injectors
01/01/2013US8342176 Sealed capsule including an integrated puncturing mechanism
12/2012
12/30/2012CA2778017A1 Novel drug eluting medical devices
12/28/2012CA2795995A1 Microneedle assembly formulation for skin treatment
12/27/2012WO2012178184A2 Removable protective shell for imaging agents and bioactive substances
12/27/2012WO2012177935A1 Compositions and methods for the treatment of cancer
12/27/2012WO2012177929A2 Methods for treating diabetes with extended release formulations of glp-1 receptor agonists
12/27/2012WO2012177842A1 Fast dissolving azaperone granulate formulation
12/27/2012WO2012177840A1 Novel formulations and methods for treating dermatological disorders or diseases
12/27/2012WO2012177756A2 Non-leaching antimicrobial wound dressing
12/27/2012WO2012177326A1 Biocompatible film with variable cross-sectional properties
12/27/2012WO2012177251A1 Pharmaceutical compositions comprising iodine and steroid and uses thereof for sinus diseases
12/27/2012WO2012177214A1 Liquid pharmaceutical composition comprising nitisinone
12/27/2012WO2012177088A1 Surface treatment method for magnetic particles, magnetic composite prepared thereby, and magnetic composite for labeling target materials
12/27/2012WO2012177031A1 Method for manufacturing bubbles for promoting the transfer of a functional material, and functional-material transfer device using same
12/27/2012WO2012176885A1 Branched amphipathic block polymer and molecular aggregate and drug delivery system using same
12/27/2012WO2012176876A1 Method for producing protein preparation
12/27/2012WO2012176865A1 Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol
12/27/2012WO2012176668A1 Lidocaine-containing cataplasm
12/27/2012WO2012176582A1 Eye-drop-type vaccine for avian influenza
12/27/2012WO2012176438A1 Sedative agent for vaporization and inhalation, and sedative perfume composition containing same
12/27/2012WO2012176215A1 A plant based antiviral composition for the treatment of hiv and hiv related acquired immuno deficiency syndrome
12/27/2012WO2012176212A1 Carrier based nanogel formulation for skin targeting.
12/27/2012WO2012176025A1 Pva-boronic acid containing copolymer compositions for protein delivery
12/27/2012WO2012176024A1 Cryogels of pva-boronic acid containing co-polymers for cell culture
12/27/2012WO2012176014A1 Imatinib mesylate oral pharmaceutical composition and process for preparation thereof
12/27/2012WO2012175996A2 Drug delivery formulations
12/27/2012WO2012175881A1 Topical film-forming composition, and use thereof for treating mycoses
12/27/2012WO2012175879A1 Film-forming composition, and use thereof for treating herpes
12/27/2012WO2012175776A1 Method for the production of micro-, sub-micro- and nano-capsules, based on milk serum proteins
12/27/2012WO2012175775A1 Phosphodiesterase inhibitors applied via the transvaginal route for the treatment of infertility
12/27/2012WO2012175747A1 Production method and dosage form
12/27/2012WO2012175737A1 Active ingredient matrix
12/27/2012WO2012175714A1 Phenylbutyrate in rectal form for the treatment of a motor neuron disease or a metabolic disease
12/27/2012WO2012175659A1 N-acetyl cysteine and composition thereof for use in the treatment of vaginal pathologies
12/27/2012WO2012175642A1 Peptide prodrugs
12/27/2012WO2012175641A1 Formulations of fluorinated stilbene suitable for pet imaging
12/27/2012WO2012175626A1 Composition comprising an onion extract and liposomes
12/27/2012WO2012175554A1 Prodrugs of (1s,9s)-9-[[(1s)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6h-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systems
12/27/2012WO2012175538A1 Bioresorbable microparticles
12/27/2012WO2012175434A1 Pharmaceutical formulations comprising vestipitant
12/27/2012WO2012175354A1 Dialysis precursor composition
12/27/2012WO2012175353A1 Dialysis precursor composition
12/27/2012WO2012175223A1 Cathepsin-binding compounds bound to a carrier and their diagnostic use
12/27/2012WO2012175085A1 Tobacco chewing gum formulation
12/27/2012WO2012174926A1 N-substituted isopropyldimethyl azulene sulfonamide derivatives, and preparation method and use thereof
12/27/2012WO2012174784A1 Cefuroxime axetil tablet and direct all-powder compression method thereof
12/27/2012WO2012174619A1 Non-lethal spray composition to self-defense
12/27/2012WO2012154725A3 Steroid-sparing effects of beta-adrenergic inverse agonists and use thereof
12/27/2012WO2012154122A3 A topical formulation for treatment of hyperkeratotic skin
12/27/2012WO2012149265A3 Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
12/27/2012WO2012142410A3 Redox responsive polymeric nanocapsules for protein delivery
12/27/2012WO2012142147A3 Synthesis and use of glycoside derivatives of propofol
12/27/2012WO2012140626A3 Continuous method for producing nanoparticles and nanoparticles obtained by means of said method
12/27/2012WO2012135808A3 Intraoperative and blood-derived adhesives
12/27/2012WO2012129576A3 System and method for biphasic transdermal iontophreotic delivery of therapeutic agents
12/27/2012WO2012128589A3 Urethane foam for use in impregnating cosmetic composition
12/27/2012WO2012127037A3 A composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative
12/27/2012WO2012125413A3 Compositions for ameliorating systemic inflammation and methods for making and using them
12/27/2012WO2012112982A3 Hydrogel encapsulated cells and anti-inflammatory drugs
12/27/2012WO2012105815A3 Biodegradable paox microspheres having cationic properties
12/27/2012WO2012093137A9 Liposome formulation suitable for treating or preventing tuberculosis
12/27/2012WO2012083900A3 Method for preparing biodegradable membranes for soft tissue regeneration
12/27/2012WO2012052565A9 A polymeric nanoparticle
12/27/2012US20120331576 Pathogen Restriction Factors
12/27/2012US20120330436 Bone graft substitute
12/27/2012US20120330423 Engineered Scaffolds for Intervertebral Disc Repair and Regeneration and for Articulating Joint Repair and Regeneration
12/27/2012US20120329936 Novel coating composition
12/27/2012US20120329876 Method and composition for stable and controlled delivery of (-)-hydroxycitric acid
12/27/2012US20120329850 Methods for treating retinopathy with extended therapeutic effect
12/27/2012US20120329766 Formulation
12/27/2012US20120329765 Medicinal targeted local lipolysis
12/27/2012US20120329670 Epitope testing using soluble hla
12/27/2012US20120329656 Formulation
12/27/2012US20120328718 Pharmaceutical compositions
12/27/2012US20120328707 Multi-particulate pharmaceutical formulation for colon absorption
12/27/2012US20120328706 Polymer particle delivery compositions and methods of use
12/27/2012US20120328705 Magnetic nanomedicine for tumor suppression and therapy
12/27/2012US20120328704 Powder compositions for inhalation
12/27/2012US20120328703 Swellable particles for drug delivery
12/27/2012US20120328702 Nanoparticle compositions
12/27/2012US20120328701 Nanoparticle compositions, formulations thereof, and uses therefor
12/27/2012US20120328700 Methods and compositions for regenerating connective tissue
12/27/2012US20120328699 Method and composition for treatment of skeletal dysplasias
12/27/2012US20120328698 Coating method
12/27/2012US20120328697 Controlled Release Solid Dose Forms
12/27/2012US20120328696 Anti-parkinsonian compound acetylsalicylic acid maltol ester
12/27/2012US20120328695 Compositions and methods for treatment of chronic fatigue
12/27/2012US20120328694 Therapeutic agent for fibroid lung
12/27/2012US20120328693 Method for enhancing immune response in the treatment of infectious and malignant diseases
12/27/2012US20120328692 Potent d-peptide antagonists of mdm2 and mdmx for anticancer therapy
12/27/2012US20120328691 Anilinopiperazine derivatives and methods of use thereof
12/27/2012US20120328690 Amniotic Membrane Preparations and Purified Compositions and Anti-Inflammation Methods
12/27/2012US20120328688 Biocompatible film with variable cross-sectional properties
12/27/2012US20120328687 Formulations of selective alpha-2 agonists and methods of use thereof
12/27/2012US20120328680 Wound Treatment Therapy
12/27/2012US20120328679 Solid pharmaceutical dispersions with enhanced bioavailability
1 ... 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 ... 2991